Log in

NASDAQ:TRVITrevi Therapeutics News Headlines

$6.98
-0.63 (-8.28 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.70
Now: $6.98
$8.49
50-Day Range
$2.66
MA: $4.54
$7.62
52-Week Range
$1.33
Now: $6.98
$8.49
Volume139,300 shs
Average Volume73,476 shs
Market Capitalization$124.55 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58

Headlines

Trevi Therapeutics (NASDAQ TRVI) News Headlines

Source:
DateHeadline
Trevi Therapeutics Inc (NASDAQ:TRVI) Short Interest UpdateTrevi Therapeutics Inc (NASDAQ:TRVI) Short Interest Update
www.americanbankingnews.com - July 5 at 4:46 PM
Trevi Therapeutics Announces Election of Dominick C. Colangelo to Board of DirectorsTrevi Therapeutics Announces Election of Dominick C. Colangelo to Board of Directors
finance.yahoo.com - June 30 at 5:13 PM
Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual ConferenceTrevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual Conference
finance.yahoo.com - June 17 at 8:31 PM
Trevi Therapeutics to Hold Virtual 2020 Annual Meeting of StockholdersTrevi Therapeutics to Hold Virtual 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 29 at 5:44 PM
Trevi Therapeutics Announces First Quarter 2020 Financial Results and Corporate UpdateTrevi Therapeutics Announces First Quarter 2020 Financial Results and Corporate Update
finance.yahoo.com - May 7 at 6:13 PM
Will Trevi Therapeutics (NASDAQ:TRVI) Spend Its Cash Wisely?Will Trevi Therapeutics (NASDAQ:TRVI) Spend Its Cash Wisely?
finance.yahoo.com - May 7 at 1:13 PM
TRVI Trevi Therapeutics, Inc. Common StockTRVI Trevi Therapeutics, Inc. Common Stock
www.nasdaq.com - April 25 at 10:55 PM
TREVI THERAPEUTICS TO PRESENT AT NEEDHAM HEALTHCARE CONFERENCETREVI THERAPEUTICS TO PRESENT AT NEEDHAM HEALTHCARE CONFERENCE
finance.yahoo.com - April 8 at 7:17 PM
AMRN, PSTV, SRG and PBFX among midday moversAMRN, PSTV, SRG and PBFX among midday movers
seekingalpha.com - March 31 at 4:03 PM
Trevi Therapeutics up 57% on advancement of key programsTrevi Therapeutics up 57% on advancement of key programs
seekingalpha.com - March 16 at 8:44 PM
TREVI THERAPEUTICS ANNOUNCES FOURTH QUARTER AND YEAR END 2019 FINANCIAL RESULTS AND CORPORATE UPDATETREVI THERAPEUTICS ANNOUNCES FOURTH QUARTER AND YEAR END 2019 FINANCIAL RESULTS AND CORPORATE UPDATE
finance.yahoo.com - March 16 at 10:43 AM
Trevi Therapeutics to Present at SVB Leerink Healthcare ConferenceTrevi Therapeutics to Present at SVB Leerink Healthcare Conference
finance.yahoo.com - February 20 at 8:13 PM
Trevi Therapeutics Announces Election of James V. Cassella, Ph.D. to Board of DirectorsTrevi Therapeutics Announces Election of James V. Cassella, Ph.D. to Board of Directors
finance.yahoo.com - February 18 at 5:26 PM
Trevi Therapeutics Inc.Trevi Therapeutics Inc.
www.barrons.com - February 14 at 10:37 PM
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Insiders Increased Their HoldingsTrevi Therapeutics, Inc. (NASDAQ:TRVI) Insiders Increased Their Holdings
finance.yahoo.com - February 7 at 2:46 PM
Biohaven Appoints Michael Heffernan To Board Of DirectorsBiohaven Appoints Michael Heffernan To Board Of Directors
www.marketwatch.com - January 31 at 6:15 PM
Will Trevi Therapeutics (TRVI) Take Off After Dismal 2019? Will Trevi Therapeutics (TRVI) Take Off After Dismal 2019?
www.rttnews.com - January 4 at 2:33 AM
Trevi Therapeutics Sees Hammer Chart Pattern: Time to Buy?Trevi Therapeutics Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - December 11 at 9:33 AM
Trevi Therapeutics, Inc. Common Stock (TRVI) SEC FilingsTrevi Therapeutics, Inc. Common Stock (TRVI) SEC Filings
www.nasdaq.com - December 9 at 12:21 PM
Trevi Therapeutics EPS beats by $0.11Trevi Therapeutics EPS beats by $0.11
seekingalpha.com - November 14 at 9:07 PM
Trevi Therapeutics Announces Third Quarter 2019 Financial Results and Recent Business DevelopmentsTrevi Therapeutics Announces Third Quarter 2019 Financial Results and Recent Business Developments
finance.yahoo.com - November 14 at 4:07 PM
Trevi Therapeutics to Present at Stifel Healthcare ConferenceTrevi Therapeutics to Present at Stifel Healthcare Conference
finance.yahoo.com - November 13 at 5:26 PM
Trevi Therapeutics (NASDAQ:TRVI) Is In A Good Position To Deliver On Growth PlansTrevi Therapeutics (NASDAQ:TRVI) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - November 8 at 3:20 PM
Trevi Therapeutics to Participate in Panel Discussion at BTIG Pain / Pruritus Management ForumTrevi Therapeutics to Participate in Panel Discussion at BTIG Pain / Pruritus Management Forum
www.nasdaq.com - September 5 at 8:49 PM
Trevi Therapeutics to Participate in Panel Discussion at BTIG Pain / Pruritus Management ForumTrevi Therapeutics to Participate in Panel Discussion at BTIG Pain / Pruritus Management Forum
finance.yahoo.com - September 5 at 8:49 PM
Trevi Therapeutics Announces Second Quarter 2019 Financial Results and Recent Business DevelopmentsTrevi Therapeutics Announces Second Quarter 2019 Financial Results and Recent Business Developments
finance.yahoo.com - August 12 at 6:11 PM
Have Insiders Been Buying Trevi Therapeutics, Inc. (NASDAQ:TRVI) Shares?Have Insiders Been Buying Trevi Therapeutics, Inc. (NASDAQ:TRVI) Shares?
finance.yahoo.com - August 9 at 3:26 PM
Trevi Therapeutics Announces First Quarter 2019 Financial Results and Recent Business DevelopmentsTrevi Therapeutics Announces First Quarter 2019 Financial Results and Recent Business Developments
finance.yahoo.com - June 14 at 5:52 AM
BMO Sees Compelling Valuation For Trevi Therapeutics At Current LevelsBMO Sees Compelling Valuation For Trevi Therapeutics At Current Levels
www.msn.com - June 3 at 3:16 PM
TREVI THERAPEUTICS, INC. (TRVI)TREVI THERAPEUTICS, INC. (TRVI)
finance.yahoo.com - May 15 at 8:15 PM
Trevi Therapeutics IPO: What You Need To KnowTrevi Therapeutics IPO: What You Need To Know
finance.yahoo.com - May 14 at 3:47 PM
Trevi Therapeutics Announces Pricing of Initial Public OfferingTrevi Therapeutics Announces Pricing of Initial Public Offering
finance.yahoo.com - May 14 at 3:47 PM
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.